Suven Life Sciences Ltd (SUVEN) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Suven Life Sciences Ltd reported sales of ₹4 Cr, operating profit of ₹-132 Cr (OPM -3,711%) and net profit of ₹-128 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
SUVEN quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 3 2 1 2 1 3 2 4 Expenses 55 41 45 53 81 106 52 136 Operating Profit -52 -39 -44 -51 -80 -103 -51 -132 OPM -2,032% -2,435% -2,981% -2,714% -8,671% -3,678% -3,331% -3,711% Other Income 4 2 1 1 4 3 7 8 Interest 0 0 0 0 0 0 0 0 Depreciation 1 2 1 1 1 1 2 2 Profit before tax -50 -39 -44 -52 -77 -102 -46 -128 Tax 0% 0% 0% 0% 0% 0% 0% 0% Net Profit -50 -39 -44 -52 -77 -102 -46 -128 EPS in Rs -2.28 -1.79 -2.01 -2.36 -3.4 -4.48 -1.73 -4.83
SUVEN profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 12 14 12 7 7 9 Expenses 134 139 140 172 291 375 Operating Profit -122 -126 -128 -166 -284 -366 OPM -1,032% -929% -1,094% -2,487% -3,999% -4,152% Other Income 5 14 29 11 14 21 Interest 1 0 0 0 0 1 Depreciation 4 7 6 6 6 6 Profit before tax -122 -118 -106 -161 -276 -352 Tax 0% 0% -1% 0% 0% - Net Profit -122 -118 -105 -161 -276 -352 EPS in Rs -5.59 -5.42 -4.82 -7.37 -10.48 -14.44 Dividend Payout 0% 0% 0% 0% 0% -
SUVEN balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 22 22 22 - 26 Reserves 354 248 88 - 565 Borrowings 2 1 0 - 17 Other Liabilities 12 14 25 - 16 Total Liabilities 389 285 135 - 624 Fixed Assets 37 28 60 - 73 CWIP 0 0 0 - 4 Investments 46 76 22 - 181 Other Assets 305 181 53 - 367 Total Assets 389 285 135 - 624
SUVEN cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity -128 -116 -115 -155 -300 Cash from Investing Activity -22 -248 94 155 -462 Cash from Financing Activity 146 396 -1 -1 757 Net Cash Flow -4 32 -22 -1 -5 Free Cash Flow -147 -119 -113 -193 -305 CFO/OP 104% 91% 95% 93% 106%
SUVEN ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 40 22 40 73 78 Inventory Days - - - - - Days Payable - - - - - Cash Conversion Cycle 40 22 40 73 78 Working Capital Days 234 265 101 -440 506 ROCE -118% -53% -36% -87% -80%